Allergies News and Research

Latest Allergies News and Research

Leading microbiologist warns of killer fungi’s increasing threat

A leading microbiologist has warned of the increasing threat that killer fungi poses to humans and the environment.

15 Jan 2015

NIAID awards contracts to support early-stage human clinical trials of infectious disease treatments

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded contracts to three organizations to support early-stage human clinical trials of investigational infectious disease treatments. The new awards for the Phase I Clinical Trial Units for Therapeutics increases the number of funded organizations under the program from two to three, expanding capacity for conducting early safety testing of novel investigational drugs.

15 Jan 2015

Study assesses therapeutic benefits of new oral immunotherapy for children allergic to wheat

The study carried out by researchers from the Centre for Plant Biotechnology and Genomics along with the Allergy Department of the Hospital Infantil Universitario Niño Jesús of Madrid have shown that, most of the children that received this new oral immunotherapy treatment were able to eat 100 grams of wheat bread without side effects. This result has overcome the risk of accidental ingestion by patients with this allergy. This research could be the basis for large clinical trials with more patients with the aim of assessing the therapeutic benefit of this new approach.

13 Jan 2015

H&P Labs announces licensing agreement to develop oral drug therapy against Ebola

H&P Labs Inc. announced an agreement with Harvard University and Brigham and Women's Hospital to license two classes of compounds in order to develop an oral drug therapy against Ebola.

8 Jan 2015

BD Medical announces FDA clearance of BD Intelliport Medication Management System

BD Medical, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, today announced that the U.S. Food and Drug Administration has cleared the BD Intelliport Medication Management System, the first-of-its-kind medication management solution for manual IV bolus injections.

From BD (Becton, Dickinson and Company) 7 Jan 2015

Johnson & Johnson begins Phase 1 trial of preventive Ebola vaccine program

Johnson & Johnson today announced the start of a Phase 1, first-in-human clinical trial of a preventive Ebola vaccine in development at its Janssen Pharmaceutical Companies.

6 Jan 2015

SAFE Family Wearables releases SAFE Kids Paxie Band for children

SAFE Family Wearables today launches the SAFE Kids Paxie Band, a fashionable GPS-enabled wearable device designed for children, with an accompanying mobile management application.

5 Jan 2015

Experimental Ebola vaccine safe and immunogenic in African population

Two experimental DNA vaccines to prevent Ebola virus and the closely related Marburg virus [1] are safe, and generated a similar immune response in healthy Ugandan adults as reported in healthy US adults earlier this year.

23 Dec 2014

Oral budesonide suspension offers hope for pediatric patients with EoE

A new formulation of oral budesonide suspension, a steroid-based treatment, is safe and effective in treating pediatric patients with eosinophilic esophagitis (EoE), according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association.

19 Dec 2014

Penn, UGA scientists awarded new contract to develop genome database for microbial pathogens

At the turn of the millennium, the cost to sequence a single human genome exceeded $50 million, and the process took a decade to complete. Microbes have genomes, too, and the first reference genome for a malaria parasite was completed in 2002 at a cost of roughly $15 million. But today researchers can sequence a genome in a single afternoon for just a few thousand dollars. Related technologies make it possible to capture information about all genes in the genome, in all tissues, from multiple individuals.

18 Dec 2014

$Nuvo Research completes WF10 Phase 2 trial in patients with refractory allergic rhinitis$

Nuvo Research completes WF10 Phase 2 trial in patients with refractory allergic rhinitis

Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of immunology and topical products, today announced that 179 patients have completed its 16-week, double-blind, placebo-controlled, Phase 2 clinical trial to investigate the safety and efficacy of WF10 in patients with refractory allergic rhinitis.

18 Dec 2014

Researchers identify a single protein as root cause of multiple allergic reactions

Johns Hopkins and University of Alberta researchers have identified a single protein as the root of painful and dangerous allergic reactions to a range of medications and other substances. If a new drug can be found that targets the problematic protein, they say, it could help smooth treatment for patients with conditions ranging from prostate cancer to diabetes to HIV

17 Dec 2014

Scientists produce novel class of molecules that could help combat cancer, other diseases

Promising treatments known as biologics are on the market and under development for many serious illnesses such as cancer, but some of them come with high risks, even lethal ones. Now scientists have produced a novel class of molecules that could be as effective but without the dangerous side effects.

17 Dec 2014

UCLA researchers develop lens-free microscope that can detect cancer, other cell-level abnormalities

UCLA researchers have developed a lens-free microscope that can be used to detect the presence of cancer or other cell-level abnormalities with the same accuracy as larger and more expensive optical microscopes.

17 Dec 2014

Most people with asthma or severe allergies do not use medical devices correctly, study finds

For people with asthma or severe allergies, medical devices like inhalers and epinephrine autoinjectors, such as EpiPen, can be lifesaving.

17 Dec 2014

Researchers discover widespread misconception about antibiotic resistance among patients

Over prescription of antibiotics is a major factor driving one of the biggest public health concerns today: antibiotic resistance. In a first-of-its-kind study, research led by the George Washington University suggests that public health educational materials may not address the misconceptions that shape why patients expect antibiotics, driving doctors to prescribe them more.

16 Dec 2014

Study: New flooring can increase risk of respiratory diseases in infants

New flooring in the living environment of pregnant women significantly increases the risk of infants to suffer from respiratory diseases in their first year of life. This is the result of a study carried out by the Helmholtz Centre for Environmental Research and the "St Georg" Municipal Hospital, which demonstrates that exposure to volatile organic compounds in the months before and after birth induces breathing problems in early childhood .

16 Dec 2014

Allergies News and Research

Latest Allergies News and Research

Leading microbiologist warns of killer fungi’s increasing threat

NIAID awards contracts to support early-stage human clinical trials of infectious disease treatments

Study assesses therapeutic benefits of new oral immunotherapy for children allergic to wheat

H&P Labs announces licensing agreement to develop oral drug therapy against Ebola

BD Medical announces FDA clearance of BD Intelliport Medication Management System

Johnson & Johnson begins Phase 1 trial of preventive Ebola vaccine program

SAFE Family Wearables releases SAFE Kids Paxie Band for children

Experimental Ebola vaccine safe and immunogenic in African population

Oral budesonide suspension offers hope for pediatric patients with EoE

Penn, UGA scientists awarded new contract to develop genome database for microbial pathogens

Nuvo Research completes WF10 Phase 2 trial in patients with refractory allergic rhinitis

Researchers identify a single protein as root cause of multiple allergic reactions

Scientists produce novel class of molecules that could help combat cancer, other diseases

UCLA researchers develop lens-free microscope that can detect cancer, other cell-level abnormalities

Most people with asthma or severe allergies do not use medical devices correctly, study finds

Researchers discover widespread misconception about antibiotic resistance among patients

Study: New flooring can increase risk of respiratory diseases in infants

Tips to allergy sufferers for easy breathing this holiday season

Brunel scientists find way to target hard-to-reach cancers using 'Trojan horse' nanoparticles

Study: Drive for energy efficient homes could raise asthma risks

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Allergies News and Research

Latest Allergies News and Research

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in